A Cross Over Study to Compare the Effect of Combined Treatment With QAV680 and Cetirizine

Clinical trial NCT01103050 · COMPLETED

Trial details

NCT number: NCT01103050
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Allergic Rhinitis

Start date: 2010-03-22
Primary completion: 2010-07-28
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.